2026年07月

Metastatic Colorectal Cancer Market Set for Strong Growth Across the 7MM (2025–2034)The metastatic colorectal cancer market is on a clear upward trajectory across the seven major markets (7MM), supported by rapid progress in targeted therapies, immunothe ... もっと読む

Uterine fibroids remain one of the most common benign gynecological conditions affecting women of reproductive age, and the shift toward less invasive care is reshaping how they are managed. As more patients and physicians move away from traditional hyste ... もっと読む

Chimeric Antigen Receptor T-cell (CAR-T) therapy has transformed the treatment landscape for hematological malignancies, offering durable remissions to patients who previously had few options left. Yet this breakthrough comes with a well-documented safety ... もっと読む

Kidney tumors present one of the more nuanced challenges in modern uro-oncology, largely because not every renal mass is malignant. Among the benign growths that clinicians regularly encounter is a distinct type of kidney tumor originating from the cells ... もっと読む

↑このページのトップヘ